Zong-Jiong Mai

Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer

Qi Zhao, Feng Wang, Yan‐Xing Chen et al. · Nature Communications · 2022 · 77 citations · Full text

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao et al. · Clinical Cancer Research · 2022 · 48 citations · Full text

RETRACTED: LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270

Aimei Zou, Xingli Liu, Zong-Jiong Mai et al. · Molecular Therapy — Nucleic Acids · 2019 · 36 citations · Full text

Nsclc Tumor Growth, Pathology, Nsclc Treatment +17

Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial.

Chao Ren, Zong-Jiong Mai, Ying Jin et al. · PubMed · 2020 · 35 citations · Full text

Tumor Biology, Phase Ii Trial, Gastrointestinal Oncology +15

Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial–mesenchymal transition

Tianwen Lai, Yanyu Li, Min Chen et al. · Laboratory Investigation · 2018 · 30 citations · Full text

Inflammation, Allergy, Copd Disease Severity +9